One step closer to becoming One Pfizer! http://www.mercknewsroom.com/press-release/research-and-development-news/merck-co-inc-and-pfizer-enter-worldwide-collaboration-ag
Yowza! Old Pfizerites must be turning in their graves. The thought that we need our sworn enemy's help speaks to our 15 year track record of ineptitude in launching blockbusters in a competitive market. Let me go to Nat Geo's website tonight so I can watch a lion pride and hyena pack work together to bring down a wildebeest.
This is a necessity. There simply are not enough of us or resources to get something like this off the ground. These phase 3 trials are high risk as seen with Eliquis. Merck has been decimated the last couple of years as has BMS. Share the risk and share the reward nowadays. I'm cool with it if it is a success. Remember this one being highlighted at the Toviaz launch during a group dinner. Speaker was a Brit on charge of drug development. Said if made it to phase 3 watch out. Bout time we get some sustained good news (Xejanz, Eliquis, Celebrex LOE, stock at $30). Keep it coming!
Fierce competitiors in the meat market turned Gay marriage. Welcome to the year twenty-thirteen. Raise the rainbow flag!
Word is that the new company will be called Mizerck (pronounced with My Jerk), which coincidentally is an old East German insult for a person thats become intellectually stunted by smoking too many drugs.
The new combined company will be called Wyeth and the lead product by revenue will be Prevnar 13, followed by Merck's conjugated pneumococcal CRM 197 Prevnar 15 in 2015.
Pfizer vaccine reps want to know when the data collaboration and information gathering meeting is with Merck for shared accounts? Vaccine reps want Merck to fill out their little Dilbert sales spreadsheets.
By the time this cluster hits the market, there will be 3 or 4 SGLT2 already on the market.....excellent move....
Vaccines it's a no brainer. Prevnar, Mmr and varivax would make for three products made by no one else. We can control the market.